Today: 7 February 2026
Subscribe
Browse Category

NYSE:UNH News 28 January 2026 - 7 February 2026

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
····
UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.
6 February 2026
·
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth Group shares fell 1.8% to $286.93 Friday as investors weighed the government’s proposed 2027 Medicare Advantage rates. The Centers for Medicare & Medicaid Services set a Feb. 25 deadline for comments and plans to announce final rates by April 6. UnitedHealth’s stock had plunged nearly 20% earlier in the week after the initial rate proposal missed analyst expectations.
1 February 2026
·
Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

The Health Care Select Sector SPDR Fund (XLV) rose 0.6% to $154.74 Friday, while the S&P 500 fell 0.43%. Healthcare and consumer staples were the only S&P sectors in positive territory as investors shifted to defensive stocks. Major managed-care shares lagged after a minimal proposed Medicare Advantage rate hike. Pfizer, Merck, and Eli Lilly report earnings next week.
1 February 2026
·····
Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

The Dow fell 179.09 points, or 0.4%, to 48,892.47 Friday after Trump named Kevin Warsh as his pick for Fed chair and producer inflation came in hotter than expected. Thom Tillis said he would block Warsh’s confirmation until a Justice Department probe into Powell ends. The S&P 500 dropped 0.43%, Nasdaq lost 0.94%. The January U.S. jobs report is due next Friday.
1 February 2026
········
UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth shares fell 1.8% to $286.93 in after-hours trading Friday after Barclays cut its price target. The stock has dropped about 18% since Monday, triggered by a 20% plunge Tuesday. UnitedHealth forecast 2026 revenue just over $439 billion, down 2% from last year, and signaled a medical care ratio of 88.8%. Several banks trimmed price targets this week, citing Medicare-related uncertainty.
31 January 2026
·
UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth Group shares fell 2.1% to $286.12 in late-morning trading Friday, extending losses after this week’s selloff. Investors focused on proposed 2027 Medicare Advantage payment changes, with the government’s comment period ending Feb. 25 and final rates due April 6. CMS projects a net average payment increase of 0.09% for 2027. UBS cut its price target for UnitedHealth to $410, citing rate uncertainty.
30 January 2026
·
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·····
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
29 January 2026
·····
UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth Group shares fell 1.2% to $290.50 Thursday after regulators proposed a 0.09% Medicare Advantage rate hike for 2027, far below expectations. The company warned of possible benefit cuts and a $1.6 billion charge tied to a cyberattack. UnitedHealth stock plunged 19% Tuesday after executives called the proposal “disappointing.” CMS will issue final rates by April 6.
29 January 2026
·
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
1 2 3 … 7

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop